| Biogen Switzerland AG - Tysabri 150 mg/ml, Injektionslösung in einer Fertigspritze |
| 68008 | | 01 | | Tysabri 150 mg/ml | | Injektionslösung in einer Fertigspritze | | L04AA23 | | Natalizumab | | 04.11.2021 | | |
|
| Composition |
| natalizumabum 150 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.45 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Natalizumab | 150 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Natalizumab | 150 mg |
| | | | Inactive agents |
|---|
| Disodium Phosphate Heptahydrate | | Sodium Chloride | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 2 | 1548.10 | 1700.05 | B | SL | No |
|
